NASDAQ · IPA
Healthcare · Biotechnology
$1.62
Up+$0.04 (+2.53%)
Updated Aug 15, 2026, 9:45 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
IPA does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning IPA.
IPA research
Company profile and research snapshot.
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Apr 11, 2025 | HC Wainwright & Co. | Buy | — |
| Apr 1, 2025 | Benchmark | Speculative Buy | — |
| Mar 31, 2025 | HC Wainwright & Co. | Buy | — |
| Mar 14, 2025 | HC Wainwright & Co. | Buy | — |
| Dec 11, 2024 | HC Wainwright & Co. | Buy | — |
No generated briefing is available yet.
globenewswire.com · Sep 16, 2025
EUGENE, Ore., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Hop Valley Brewing Co. (“Hop Valley Brewing” or “Hop Valley”), a trailblazer in the craft brewing industry and brand by Tilray Brands, Inc.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning IPA.
No results
No recent SID articles mention IPA.
